iollo
Summer 2022 · Active
Building Quinn, an AI scientist accelerating pharma/biotech R&D
Location: San Francisco, US
Founded: 2022
Team size: 4
About
We're building Quinn at iollo, an AI scientist that analyzes multimodal biological data (multi-omics, imaging, etc.) to discover new biology in hours, work that typically takes teams of scientists years. Quinn translates these discoveries into accelerated development of novel therapeutic strategies and interventions for extending healthspan.
Founders
Daniel GomariFounder/CEO
Daniel Gomari is the founder and CEO of iollo. He was previously a postdoctoral researcher at Stanford University where he led projects on healthy aging and lifespan extension. He received his PhD in Computational Biology, where he built and applied machine learning methods for drug repurposing, with applications in cancer and diabetes patient metabolomics data.